NOV 02, 2016 10:30 AM PDT

Tough Targets. Simple Genotyping. Using HRM as a direct approach in research applications.

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Senior Marketing Specialist, Canon BioMedical
    Biography
      Brian McNally received his doctorate in Cell & Molecular Biology at University of Texas Southwestern Medical Center, where he focused on the transcriptional mechanisms governing polycystic kidney disease, renal cancer and development. His post-doctoral fellowship concentrated on the regulatory relationship between the proteasome and Toll-like receptor signaling at the University of Maryland Medical School in the Department of Immunology and Microbiology. Brian has fifteen years of practical experience at the laboratory bench, and his work has been published in peer-reviewed journals and presented at international conferences. In 2008, he transitioned to industry to commercialize new biomedical products including assays, reagents and software. Brian has been with Canon BioMedical since its inception last year. He is passionate about partnering with life scientists to develop the next wave of biomedical solutions.

    Abstract:

    Are there DNA targets in your lab that are difficult to genotype using standard PCR or sequencing?
    Do you ever need to genotype a single sample, and you don’t want to wait to batch samples together?
    Are you testing mitochondrial DNA targets? High-resolution melting (HRM) is a PCR-based solution
    that addresses focused genotyping needs. We have developed a library of common and unique
    targets for identifying single nucleotide polymorphisms (SNPs), small indels, and large deletions.
    Using any HRM-enabled thermocycler you get conclusive results in a variety of research areas,
    including cancer, neuroscience, and pharmacogenetics.

    Canon BioMedical was established last year to develop innovative technologies and solutions that
    empower biomedical research and healthcare communities. Our Novallele™ products aim to support
    researchers with 311 targeted genotyping assays as well as laboratory-verified, fast chemistry
    reagents.

    Join us to discuss how our Novallele assays can answer your difficult genotyping questions.

    Learning objectives:
    1. Learn about HRM technology, a PCR-based method for rapid mutation detection.
    2. Learn the mutation types detected with HRM through specific research application examples.


    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    Loading Comments...